Draig Therapeutics

📍 Cardiff, United Kingdom👥 24 employees💰 Last funded Jun 2025
Biotechnology Research🌐 draigtherapeutics.com
Website LinkedIn
Draig Therapeutics is a clinical-stage company with a mission to transform treatments in Neuropsychiatry. The company is leveraging its founders’ unique scientific expertise in modulating the core glutamate / GABA pathways that play a critical role in neuropsychiatric diseases to advance a pipeline of groundbreaking therapies designed to address large unmet patient needs, including in Major Depressive Disorder (MDD). Draig is the Welsh word for ‘dragon’ and it reflects the company’s origins in Wales. The name and logo were inspired by this heritage, reflecting its scientific roots stemming from Cardiff University.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Draig Therapeutics?
Draig Therapeutics has 1 investors on record on gritt.io.
When did Draig Therapeutics last raise funding?
The most recent investment in Draig Therapeutics recorded on gritt.io was in June 2025.
What industry is Draig Therapeutics in?
Draig Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Draig Therapeutics based?
Draig Therapeutics is headquartered in Cardiff, United Kingdom.